TCMD חוב כולל להון Tactile Medical

Tactile Systems Technology (TCMD) generates revenue through the supply of high-margin Flexitouch portable compression systems for the treatment of venous insufficiency. Income is based on the sale of edema management systems and prescription ancillary materials. This chart illustrates a total debt-to-equity ratio of 0.06. The brand is considered the gold standard for reliability in home lymphedema treatment, enjoying the absolute trust of the medical community.

This indicator measures the ratio of total liabilities to equity, determining the company's level of financial leverage. Investors evaluate the debt-to-equity ratio to analyze a company's resilience to rising refinancing costs. High values signal risk, while low values indicate conservative management. For Tactile Systems Technology (TCMD), moderate leverage supports the scaling of production for its unique pneumatic systems. This ensures the accessibility of home lymphedema treatment without dependence on clinics.